Sign in to view content

Elevatum Study Design and Rationale: A Phase 4 Trial of Faricimab (VABYSMO) in Underrepresented Patients With Diabetic Macular Edema

Joseph M. Coney, MD, FASRS

Video
Published 2023

Related

Outcomes of DRCR Network Treatment Regimen Starting With Observation for Eyes With Center-involved DME and Good Visual Acuity
Omar S. Punjabi, MD
Annual Meeting Talks
2019
Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker For the Treatment of Diabetic Macular Edema (DME)
Victor Hugo Gonzalez, MD
Annual Meeting Talks
2024
Efficacy, Safety, and Durability of Faricimab in Diabetic Macular Edema (DME): One-Year Results From the Phase 3 YOSEMITE and RHINE Trials
Caroline Baumal, MD, FASRS
Annual Meeting Talks
2021

Category: Diabetic Retinopathy

See more